FVLCX
Price
$19.77
Change
+$0.11 (+0.56%)
Updated
Jan 23 closing price
Net Assets
30.6M
RMEBX
Price
$57.15
Change
+$0.51 (+0.90%)
Updated
Jan 23 closing price
Net Assets
104.41B
Ad is loading...

FVLCX vs RMEBX

Header iconFVLCX vs RMEBX Comparison
Open Charts FVLCX vs RMEBXBanner chart's image
Fidelity Advisor Value Leaders C
Price$19.77
Change+$0.11 (+0.56%)
VolumeN/A
Net Assets30.6M
American Funds American Mutual R2E
Price$57.15
Change+$0.51 (+0.90%)
VolumeN/A
Net Assets104.41B
FVLCX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FVLCX vs. RMEBX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVLCX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. FVLCX (30.6M). RMEBX pays higher dividends than FVLCX: RMEBX (1.54) vs FVLCX (0.50). FVLCX was incepted earlier than RMEBX: FVLCX (22 years) vs RMEBX (10 years). FVLCX is a more actively managed with annual turnover of: 40.00 vs. RMEBX (25.00). FVLCX has a lower initial minimum investment than RMEBX: FVLCX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 13.63 vs. FVLCX (-2.65). RMEBX return over 5 years is better than : 40.60 vs. FVLCX (7.23).
FVLCXRMEBXFVLCX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years10 years-
Gain YTD1.9074.09847%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets30.6M104B0%
Annual Yield % from dividends0.501.5432%
Returns for 1 year-2.6513.63-19%
Returns for 3 years-2.2116.79-13%
Returns for 5 years7.2340.6018%
Returns for 10 years25.0564.9739%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR174.112.21
+1.29%
First Solar
AAMI25.660.26
+1.02%
Acadian Asset Management Inc
SHC13.690.09
+0.66%
Sotera Health Company
VERI3.15-0.03
-0.94%
Veritone
ACXP0.83-0.02
-2.36%
Acurx Pharmaceuticals